Boston Scientific Corporation Revenue 2007–2025
Boston Scientific Corporation annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Boston Scientific Corporation revenue for the quarter ending March 31, 2026 was 5.2 B, a 11.58% increase year-over-year.
- Boston Scientific Corporation revenue for the twelve months ending March 31, 2026 was 20.0 B, a 27.24% increase year-over-year.
- Boston Scientific Corporation annual revenue for 2025 was 20.1 B, a 19.87% increase from 2024.
- Boston Scientific Corporation annual revenue for 2024 was 16.7 B, a 17.61% increase from 2023.
- Boston Scientific Corporation annual revenue for 2023 was 14.2 B, a 12.29% increase from 2022.
- Boston Scientific Corporation annual revenue for 2022 was 12.7 B.
Boston Scientific Corporation (BSX) — Frequently Asked Questions
Boston Scientific Corporation (BSX) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $72.24B. In fiscal 2025 it reported revenue of $20.07B. Explore BSX's stock price, financial statements, earnings history, margins and key ratios below.
What is Boston Scientific Corporation's market cap?
Boston Scientific Corporation (BSX) has a market capitalization of $72.24B.
What is the BSX stock price?
BSX trades at $48.34 (-1.27% on the day).
How much revenue does Boston Scientific Corporation make?
Boston Scientific Corporation reported revenue of $20.07B in fiscal 2025.